• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的严重程度与尿石症风险相关。

The severity of NAFLD is associated with the risk of urolithiasis.

作者信息

Qin S, Wang J, Zhou C, Zhang Y, Xu Y, Wang X, Wang S

机构信息

a Department of Gastroenterology and Hepatology , China-Japan Union Hospital of Jilin University , Changchun , China.

b Department of Urology , the First Hospital of Jilin University , Changchun , China.

出版信息

Br J Biomed Sci. 2019 Apr;76(2):53-58. doi: 10.1080/09674845.2018.1548743. Epub 2018 Dec 17.

DOI:10.1080/09674845.2018.1548743
PMID:30430908
Abstract

BACKGROUND AND AIMS

Population-based studies suggest a strong association between the presence of nonalcoholic fatty liver disease (NAFLD) and an increased risk of urolithiasis. However, the available information on the association of the severity of NAFLD with urolithiasis is limited. We hypothesised a link between the severity of NAFLD and the risk of urolithiasis.

METHODS

We recruited 1527 adult patients with NAFLD who completed a comprehensive health checkup. The severity of NAFLD was measured with AST to platelet ratio (APRI score). Logistic regression analysis was used to detect the association of APRI score with the risk of urolithiasis among NAFLD patients. ROC analysis was used to assess the diagnostic value of APRI score for identifying urolithiasis among NAFLD patients.

RESULTS

Multivariate analysis showed three independent risk factors for urolithiasis: obesity (OR 2.06 95%CI 1.35-3.13), APRI score (OR 1.29 95%CI 1.05-1.59), and serum uric acid (OR 1.07 95%CI 1.05-1.09), suggesting an independent association between the noninvasive staging of liver fibrosis and the risk of urolithiasis in NAFLD patients. A three-variable model (obesity, APRI score, and serum uric acid) with an AUROC of 0.73 (95% CI 0.70-0.75) was significant in identifying urolithiasis.

CONCLUSIONS

The severity of NAFLD is associated with the risk of urolithiasis among NAFLD patients. Moreover, a three-variable model (obesity, APRI score, serum uric acid) could serve as a useful tool for identifying individuals at high risk for urolithiasis in these patients.

摘要

背景与目的

基于人群的研究表明,非酒精性脂肪性肝病(NAFLD)的存在与尿石症风险增加之间存在密切关联。然而,关于NAFLD严重程度与尿石症关联的现有信息有限。我们推测NAFLD的严重程度与尿石症风险之间存在联系。

方法

我们招募了1527名完成全面健康检查的成年NAFLD患者。使用天冬氨酸转氨酶与血小板比值(APRI评分)来衡量NAFLD的严重程度。采用逻辑回归分析来检测APRI评分与NAFLD患者尿石症风险之间的关联。使用ROC分析来评估APRI评分在识别NAFLD患者尿石症方面的诊断价值。

结果

多变量分析显示尿石症的三个独立危险因素:肥胖(OR 2.06,95%CI 1.35 - 3.13)、APRI评分(OR 1.29,95%CI 1.05 - 1.59)和血清尿酸(OR 1.07,95%CI 1.05 - 1.09),这表明肝纤维化的非侵入性分期与NAFLD患者尿石症风险之间存在独立关联。一个包含肥胖、APRI评分和血清尿酸的三变量模型,其曲线下面积(AUROC)为0.73(95%CI 0.70 - 0.75),在识别尿石症方面具有显著意义。

结论

NAFLD的严重程度与NAFLD患者的尿石症风险相关。此外,一个包含肥胖、APRI评分、血清尿酸的三变量模型可作为识别这些患者中尿石症高危个体的有用工具。

相似文献

1
The severity of NAFLD is associated with the risk of urolithiasis.非酒精性脂肪性肝病的严重程度与尿石症风险相关。
Br J Biomed Sci. 2019 Apr;76(2):53-58. doi: 10.1080/09674845.2018.1548743. Epub 2018 Dec 17.
2
The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study.中国非酒精性脂肪性肝病(NAFLD)患者中无创肝纤维化评分与尿石症的关联:一项横断面研究。
BMJ Open. 2019 Aug 30;9(8):e027702. doi: 10.1136/bmjopen-2018-027702.
3
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
4
Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.拉丁人群中非酒精性脂肪性肝病无创性纤维化诊断系统的验证研究。
Ann Hepatol. 2013 May-Jun;12(3):416-24.
5
AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.天门冬氨酸氨基转移酶与血小板比值指数和纤维化 4 计算器评分用于非酒精性脂肪性肝病患者肝纤维化的无创评估。
Dig Liver Dis. 2017 Oct;49(10):1133-1138. doi: 10.1016/j.dld.2017.05.002. Epub 2017 May 11.
6
Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.非酒精性脂肪性肝病患者的非侵入性肝纤维化检测:一个外部验证队列
Horm Metab Res. 2019 Feb;51(2):134-140. doi: 10.1055/a-0713-1330. Epub 2018 Oct 1.
7
Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.脂肪变性严重程度影响非酒精性脂肪性肝病无创性纤维化检测的诊断性能。
Liver Int. 2018 Feb;38(2):331-341. doi: 10.1111/liv.13549. Epub 2017 Sep 5.
8
Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肥胖和体重增加与非酒精性脂肪性肝病患者肝纤维化进展相关。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):543-550.e2. doi: 10.1016/j.cgh.2018.07.006. Epub 2018 Sep 11.
9
The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患儿肝纤维化评分的评估
Dig Dis Sci. 2015 May;60(5):1440-7. doi: 10.1007/s10620-014-3494-7. Epub 2014 Dec 25.
10
The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.非侵入性评分在评估2型糖尿病患者非酒精性脂肪性肝病和晚期肝纤维化患病率中的应用
J Clin Gastroenterol. 2018 Mar;52(3):268-272. doi: 10.1097/MCG.0000000000000905.

引用本文的文献

1
Metabolic dysfunction-associated fatty liver disease as a mediator of urolithiasis risk: evidence from cross-sectional and genetic studies.代谢功能障碍相关脂肪性肝病作为尿路结石风险的介导因素:来自横断面研究和遗传学研究的证据
Int J Med Sci. 2025 Jan 21;22(4):764-774. doi: 10.7150/ijms.106824. eCollection 2025.
2
Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study.代谢功能障碍相关脂肪性肝病与肾结石风险:一项大规模横断面研究
Front Endocrinol (Lausanne). 2025 Jan 21;15:1406065. doi: 10.3389/fendo.2024.1406065. eCollection 2024.
3
Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease.
胆结石病、非酒精性脂肪性肝病、肾结石病之间的双向关联
World J Gastroenterol. 2024 Dec 14;30(46):4914-4928. doi: 10.3748/wjg.v30.i46.4914.
4
Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease.探索胆结石病、非酒精性脂肪性肝病和肾结石病相互关联动态的见解。
World J Gastroenterol. 2024 Dec 14;30(46):4977-4982. doi: 10.3748/wjg.v30.i46.4977.
5
A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.两样本孟德尔随机化分析排除了非酒精性脂肪性肝病与肾结石之间的因果关系。
Front Endocrinol (Lausanne). 2024 Jan 10;14:1343367. doi: 10.3389/fendo.2023.1343367. eCollection 2023.
6
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的尿结石形成谱
Nephrol Dial Transplant. 2023 Oct 31;38(11):2652-2654. doi: 10.1093/ndt/gfad106.